These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22100357)

  • 1. Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients.
    Neziri AY; Dickenmann M; Scaramozzino P; Andersen OK; Arendt-Nielsen L; Dickenson AH; Curatolo M
    Pain; 2012 Feb; 153(2):311-318. PubMed ID: 22100357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One failed clinical trial (of 5HT3 antagonists) does not invalidate the concept.
    Förster M; Baron R
    Pain; 2012 Feb; 153(2):263-264. PubMed ID: 22154218
    [No Abstract]   [Full Text] [Related]  

  • 3. Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron.
    Nasirinezhad F; Hosseini M; Karami Z; Yousefifard M; Janzadeh A
    J Spinal Cord Med; 2016; 39(2):212-9. PubMed ID: 26338446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropisetron blocks analgesic action of acetaminophen: a human pain model study.
    Bandschapp O; Filitz J; Urwyler A; Koppert W; Ruppen W
    Pain; 2011 Jun; 152(6):1304-1310. PubMed ID: 21420788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic low back pain with tropisetron.
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2004; 119():76-8. PubMed ID: 15515421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of paracetamol and tropisetron on pain: experimental studies and a review of published data.
    Tiippana E; Hamunen K; Kontinen V; Kalso E
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):124-31. PubMed ID: 22905891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
    Pickering G; Loriot MA; Libert F; Eschalier A; Beaune P; Dubray C
    Clin Pharmacol Ther; 2006 Apr; 79(4):371-8. PubMed ID: 16580905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
    Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
    Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study.
    Sanga P; Polverejan E; Wang S; Kelly KM; Thipphawong J
    Clin Ther; 2016 Jun; 38(6):1435-1450. PubMed ID: 27101815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
    Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
    Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
    Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
    Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
    Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia.
    Vergne-Salle P; Dufauret-Lombard C; Bonnet C; Simon A; Trèves R; Bonnabau H; Bertin P
    Eur J Pain; 2011 May; 15(5):509-14. PubMed ID: 21036635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone.
    Samborski W; Stratz T; Mackiewicz S; Müller W
    Scand J Rheumatol Suppl; 2004; 119():51-4. PubMed ID: 15515415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
    Haus U; Varga B; Stratz T; Späth M; Müller W
    Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions--preliminary clinical experience.
    Hrycaj P
    Scand J Rheumatol Suppl; 2004; 119():55-8. PubMed ID: 15515416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropisetron alleviate early post-operative pain after gynecological laparoscopy in sevoflurane based general anaesthesia: a randomized, parallel-group, factorial study.
    Mei W; Li M; Yu Y; Cheung CW; Cao F; Nie B; Zhang Z; Wang P; Tian Y
    Eur J Pain; 2014 Feb; 18(2):238-48. PubMed ID: 23868810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
    J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias].
    Stratz T; Müller W
    Fortschr Med Orig; 2002; 120(1):17-20. PubMed ID: 14518353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents.
    Metaxari M; Papaioannou A; Petrou A; Chatzimichali A; Pharmakalidou E; Askitopoulou H
    J Anesth; 2011 Jun; 25(3):356-62. PubMed ID: 21431625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.